相关实验视频
Updated: Sep 18, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
871
慢性病治疗的未来:组合疗法 (多药片) 或生物标志物引导的个性化干预?
Sajjad Biglari1,2, Harald Mischak1, Joachim Beige3,4
1Mosaiques Diagnostics GmbH, 30659 Hannover, Germany.
Biomolecules
|June 26, 2025
概括
本综述探讨了慢性病 (CKD) 药物治疗的最新进展,重点关注药物组合和使用生物标志物进行个性化治疗,以获得更好的患者结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 生物标志物 生物标志物
背景情况:
- 慢性病 (CKD) 是一个重要的全球健康问题,发病率和成本不断上升.
- 当前的医疗保健系统在管理不断增长的CKD患者群体方面面临着挑战.
研究的目的:
- 从2020-2025年提供对CKD药物治疗进展的深入评估.
- 强调药物组合和生物标志物引导治疗在个性化CKD管理中的作用.
主要方法:
- 对2020年至2025年间发表的研究进行系统的文献搜索.
- 叙述性综述综合了关于CKD药物治疗,药物组合和预测生物标志物的发现.
主要成果:
- 药物组合有可能改善CKD的结果,但会带来不良影响和成本的风险.
- 基于生物标志物的方法使个性化CKD治疗能够根据个体分子形状量身定制.
- 介绍了基于治疗应答标记的指导CKD治疗的当前方法.
结论:
- 使用生物标志物的个性化医疗对优化CKD治疗策略具有前景.
- 结合药物治疗和以生物标志物为指导的方法可能会导致更有效的CKD管理.
- 对量身定制疗法的进一步研究可以改善患者的治疗结果,并减少医疗保健负担.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
84
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
84
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Chronic Kidney Disease I: Introduction
76
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
76
Chronic Kidney Disease IV: Nursing Management
61
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
61
Acute Kidney Injury V: Interprofessional Care
51
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
51
Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107

